Xarelto Lawsuit Filed After User Suffers Subdural Hemorrhage

September 29, 2016 – – TheProductLawyers.com reports on the death of a Xarelto user who suffered a subdural hemorrhage which doctors were unable to stop since the drug remained in his system. His widow alleges the hemorrhage was caused by taking Xarelto, a blood-thinning drug manufactured by Janssen Pharmaceuticals, a subsidiary of the Johnson and Johnson Corporation, and Bayer Healthcare. The widow has filed a lawsuit against the makers of the drug claiming that they did not sufficiently warn consumers about the dangerous bleeding risks associated with the drug. Her case was originally filed in the State of Florida but is now part of the 2,800 cases that have been consolidated by a decision of the U.S. Judicial Panel on Multidistrict Litigation (JPML). The multidistrict litigation (MDL 2592) cases are being overseen in federal court in the Eastern District of Louisiana under the administrative hand of Judge Eldon Fallon.

In addition to the cases encompassed in MDL 2592, there are 550 more cases that the Court of Common Pleas in Philadelphia, Pennsylvania has consolidated in a mass tort program.

The U.S. Food and Drug Administration approved Xarelto to be released to the consumer market in 2011. At the time, Xarelto was touted as a successful, new-generation blood thinner as it was unlike its predecessor drugs. With Xarelto, patients no longer had to follow strict, special diets nor did they have to be continually monitored by medical professionals. Unfortunately, this excitement over the drug and its benefits was short lived as lawsuits began to accumulate. Today, many plaintiffs that have filed lawsuits against the manufacturers of the drug claiming it puts patients at increased risks of suffering uncontrollable, and sometimes fatal, bleeding episodes. The FDA seems to concur since it has issued two black box warnings against Xarelto. Black box warnings are the harshest warnings the FDA can give to a product and many times it is a precursor to it being taken off the market.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-478-9711.

###

Contact TheProductLawyers.com:

Banville Law
888-478-9711
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60012381